IR-Med Inc. (IRME)
OTCMKTS: IRME · Delayed Price · USD
0.650
+0.050 (8.33%)
Jul 23, 2024, 2:06 PM EDT - Market closed
IR-Med Market Cap
IR-Med has a market cap or net worth of $45.95 million as of July 24, 2024. Its market cap has increased by 70.30% in one year.
Market Cap
45.95M
Enterprise Value
45.87M
1-Year Change
70.30%
Ranking
n/a
Category
Stock Price
Market Cap Chart
Since July 24, 2019, IR-Med's market cap has decreased from $520.34M to $45.95M, a decrease of -91.17%. That is a compound annual growth rate of -38.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 37.06M | -53.89% |
| Dec 29, 2023 | 80.38M | 133.64% |
| Dec 30, 2022 | 34.40M | -75.79% |
| Dec 31, 2021 | 142.12M | 43.63% |
| Dec 31, 2020 | 98.95M | -93.42% |
| Dec 31, 2019 | 1.50B | 188.89% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 823.02B |
| Novo Nordisk | 592.72B |
| UnitedHealth Group | 514.06B |
| Johnson & Johnson | 371.21B |
| Merck & Co. | 318.35B |
| AbbVie | 306.57B |
| AstraZeneca | 245.44B |
| Novartis AG | 212.73B |